相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protective effect and mechanism of ginsenoside Rg2 on atherosclerosis
Qianqian Xue et al.
JOURNAL OF GINSENG RESEARCH (2023)
Role of OSCAR Signaling in Osteoclastogenesis and Bone Disease
Iva R. Nedeva et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Phenolic Compounds and Ginsenosides in Ginseng Shoots and Their Antioxidant and Anti-Inflammatory Capacities in LPS-Induced RAW264.7 Mouse Macrophages
Fan Yao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Anti-inflammatory effect of Vaccinium oldhamii stems through inhibition of NF-κB and MAPK/ATF2 signaling activation in LPS-stimulated RAW264.7 cells
Ha Na Kim et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
SIRT5 promotes IDH2 desuccinylation and G6PD deglutarylation to enhance cellular antioxidant defense
Lisha Zhou et al.
EMBO REPORTS (2016)
Ginsenoside Rg2 induces orphan nuclear receptor SHP gene expression and inactivates GSK3β via AMP-activated protein kinase to inhibit hepatic glucose production in HepG2 cells
Hai-Dan Yuan et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2012)
Ginsenoside Rg3 attenuates cell migration via inhibition of aquaporin 1 expression in PC-3M prostate cancer cells
Xue-Yang Pan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Mangiferin Attenuates Osteoclastogenesis, Bone Resorption, and RANKL-Induced Activation of NF-kappa B and ERK
Estabelle Ang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Evidence for osteocyte regulation of bone homeostasis through RANKL expression
Tomoki Nakashima et al.
NATURE MEDICINE (2011)
Epigallocatechin-3-gallate Inhibits Osteoclastogenesis by Down-Regulating c-Fos Expression and Suppressing the Nuclear Factor-kappa B Signal
Jong-Ho Lee et al.
MOLECULAR PHARMACOLOGY (2010)
20(R)-Ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicity
Jie Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
The osteoclast: Friend or foe?
Deborah V. Novack et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Ginsenosides Rg1 and Rb1 enhance glutamate release through activation of protein kinase A in rat cerebrocortical nerve terminals (synaptosomes)
Yi Chang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Effect of ginseng mixture on osteoporosis in ovariectomized rats
Hyung-Ryong Kim et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2008)
Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia
Guizhi Zhang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2008)
Ginsenoside Rg1 exerts estrogen-like activities via ligand-independent activation of ER alpha pathway
Wai-Sum Lau et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Suppression of osteoclastogenesis by N,N-dimethyl-D-erythro-sphingosine:: A sphingosine kinase inhibition-independent action
Hyung Joon Kim et al.
MOLECULAR PHARMACOLOGY (2007)
NF-κB p50 and p52 regulate receptor activator of NF-κB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1
Teruhito Yamashita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Hiroshi Takayanagi
NATURE REVIEWS IMMUNOLOGY (2007)
Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1
WF Chen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Fos/AP-1 proteins in bone and the immune system
EF Wagner et al.
IMMUNOLOGICAL REVIEWS (2005)
Regulation of the transcriptional activity of c-Fos by ERK:: A novel role for the prolyl isomerase Pin1
P Monje et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis
J Gohda et al.
EMBO JOURNAL (2005)
Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation
F Ikeda et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment
A Rivollier et al.
BLOOD (2004)
Genetic regulation of osteoclast development and function
SL Teitelbaum et al.
NATURE REVIEWS GENETICS (2003)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts
S Takeshita et al.
NATURE MEDICINE (2002)
The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation
SE Lee et al.
BONE (2002)
Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-κB ligand (RANKL)
M Matsumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism
J Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Therapeutic approaches to bone diseases
GA Rodan et al.
SCIENCE (2000)
分享论文
